Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $58.73 million. The enterprise value is $62.94 million.
Important Dates
The next estimated earnings date is Tuesday, December 10, 2024, after market close.
| Earnings Date | Dec 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.59 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 13.59M |
| Shares Outstanding | 13.59M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +3.30% |
| Owned by Insiders (%) | 26.33% |
| Owned by Institutions (%) | 12.13% |
| Float | 4.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 29.79 |
| PS Ratio | 1.13 |
| Forward PS | 1.43 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69
| Current Ratio | 0.69 |
| Quick Ratio | 0.62 |
| Debt / Equity | n/a |
| Debt / EBITDA | 11.26 |
| Debt / FCF | n/a |
| Interest Coverage | -108.57 |
Financial Efficiency
Return on equity (ROE) is -432.46% and return on invested capital (ROIC) is -22.31%.
| Return on Equity (ROE) | -432.46% |
| Return on Assets (ROA) | -6.93% |
| Return on Capital (ROIC) | -22.31% |
| Revenue Per Employee | $245,976 |
| Profits Per Employee | -$16,176 |
| Employee Count | 210 |
| Asset Turnover | 1.88 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -39,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.02% in the last 52 weeks. The beta is 0.49, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -21.02% |
| 50-Day Moving Average | 4.48 |
| 200-Day Moving Average | 4.85 |
| Relative Strength Index (RSI) | 47.74 |
| Average Volume (20 Days) | 11,423 |
Short Selling Information
The latest short interest is 189,498, so 1.39% of the outstanding shares have been sold short.
| Short Interest | 189,498 |
| Short Previous Month | 200,104 |
| Short % of Shares Out | 1.39% |
| Short % of Float | 3.96% |
| Short Ratio (days to cover) | 16.30 |
Income Statement
In the last 12 months, CSBR had revenue of $51.66 million and -$3.40 million in losses. Loss per share was -$0.25.
| Revenue | 51.66M |
| Gross Profit | 22.87M |
| Operating Income | -3.04M |
| Pretax Income | -7.31M |
| Net Income | -3.40M |
| EBITDA | -1.17M |
| EBIT | -3.04M |
| Loss Per Share | -$0.25 |
Full Income StatementBalance Sheet
The company has $2.89 million in cash and $7.11 million in debt, giving a net cash position of -$4.22 million or -$0.31 per share.
| Cash & Cash Equivalents | 2.89M |
| Total Debt | 7.11M |
| Net Cash | -4.22M |
| Net Cash Per Share | -$0.31 |
| Equity (Book Value) | -332,000 |
| Book Value Per Share | -0.02 |
| Working Capital | -5.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.84 million and capital expenditures -$168,000, giving a free cash flow of -$2.00 million.
| Operating Cash Flow | -1.84M |
| Capital Expenditures | -168,000 |
| Free Cash Flow | -2.00M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
Gross margin is 44.27%, with operating and profit margins of -5.89% and -6.58%.
| Gross Margin | 44.27% |
| Operating Margin | -5.89% |
| Pretax Margin | -6.65% |
| Profit Margin | -6.58% |
| EBITDA Margin | -2.26% |
| EBIT Margin | -5.89% |
| FCF Margin | -13.90% |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | -0.23% |
| Earnings Yield | -5.78% |
| FCF Yield | -3.41% |
Analyst Forecast
The average price target for CSBR is $6.00, which is 38.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 38.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 17.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
CSBR has an Altman Z-Score of -1.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.52 |
| Piotroski F-Score | 3 |